Download PDF

Other users also viewed these articles

Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society Juan Pedro-Botet; Francisco Arrieta; Manuel Botana; José A. Gimeno-Orna; José I. Martínez-Montoro; Emilio Ortega-Martínez de Victoria; Josep Ribalta; Víctor Sánchez-Margalet; Antonio Pérez-Pérez;
Endocrinol Diabetes Nutr. 2025;72:
Continuity of care in obesity clinical care Irene Bretón; José Manuel Fernández García; Nuria Vilarrasa; Violeta Ramírez Arroyo; Ani de Hollanda; Guadalupe Blay Cortés; María D. Ballesteros-Pomar;
10.1016/j.endien.2025.501658
Hyperthyroidism and cardiovascular risk factors: A nationwide study Pedro Iglesias; Juan J. Díez;
Endocrinol Diabetes Nutr. 2023;70:255-61